## Abstract ## BACKGROUND To the authors' knowledge, little is known to date regarding the prognostic relevance of measuring serum levels of vascular endothelial growth factor (VEGF), a potent stimulator of angiogenesis, in patients with colon carcinoma who undergo surgery. ## METHODS Preoperati
Elevated levels of vascular endothelial growth factor in serum of patients with D+ HUS
β Scribed by D. Maroeska te Loo; Nienke Bosma; Victor Hinsbergh; Paul Span; Rob Waal; Ruud Clarijs; C. Sweep; Leo Monnens; Lambertus van den Heuvel
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 327 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0931-041X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
I read with interest the article by Kettritz et al. 1 regarding the accuracy of stereotactic 11-gauge vacuum-assisted breast biopsy (VAB) for diagnosing breast cancer in nonpalpable breast lesions. Of the 2893 VAB procedures performed, 19 (0.7%) yielded findings that were not representative, whereas
It is known that vascular endothelial growth factor (VEGF) family is an important role in vasculogenesis and angiogenesis. Among the VEGF family members, VEGF-A plays an essential role in angiogenesis. However, the significance of serum levels of other VEGF members (VEGF-C and -D) has been reported
## Background: Angiogenesis is essential for tumor growth and metastasis. vascular endothelial growth factor (vegf) is the most potent angiogenic factor identified to date. the authors investigated the correlation between the levels of serum vegf (s-vegf) in patients with nasopharyngeal carcinoma (